Prestige Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 14 shareholders own 60.5% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
24.7%	Prestige BioPharma Limited	15,206,560	₩73.0b	0%	no data
12.7%	So-Yeon Park	7,807,821	₩37.5b	0%	no data
12.5%	Jinwoo Kim	7,711,601	₩37.0b	0%	no data
5.28%	Octava Fund Limited	3,248,584	₩15.6b	0%	no data
3.2%	Plousios Bio No. 1 Co., Ltd.	1,970,163	₩9.5b	0%	no data
1.29%	Plousios Bio No. 2 Co., Ltd.	792,851	₩3.8b	0%	no data
0.44%	Joon-young Gwak	270,970	₩1.3b	0%	no data
0.13%	Hyuncheol Dong	80,000	₩384.0m	0%	no data
0.073%	Jae-Yeong Yang	45,000	₩216.0m	0%	no data
0.045%	Deok-hun Hyeon	27,962	₩134.2m	0%	no data
0.03%	Youngsu Lim	18,449	₩88.6m	0%	no data
0.026%	Lai Way Tay	15,792	₩75.8m	0%	no data
0.022%	State Street Global Advisors, Inc.	13,665	₩65.6m	0%	no data
0.0032%	Seok-jae Seo	2,000	₩9.6m	0%	no data